Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Published: Thursday 12th December 2024
ADVANCED SEARCH
Log in
Top
BMC Endocrine Disorders
Published in:

Open Access 01-12-2024 | Polycystic Ovary Syndrome | Research

Body composition analysis in women with polycystic ovary syndrome: a cross-sectional study from the Tehran Lipid and Glucose Study (TLGS)

Authors: Anahita Zakeri, Amir Ebadinejad, Maryam Rahmati, Amir Abbas Momenan, Mahtab Niroomand, Majid Valizadeh, Fereidoun Azizi, Fahimeh Ramezani Tehrani, Farhad Hosseinpanah

Published in: BMC Endocrine Disorders | Issue 1/2024

Login to get access

Abstract

Background

Obesity is associated with the development of polycystic ovarian syndrome (PCOS), a complex endocrine disorder. However, the correlation between body composition and PCOS in women has not been thoroughly investigated. This study aimed to examine body composition using bioelectrical impedance analysis (BIA) in women with and without PCOS in a population-based study within the Tehran Lipid and Glucose Study (TLGS).

Methods

We conducted a cross-sectional study among non-menopausal women aged 18–45 who underwent BIA in phase VII of the TLGS. A total of 150 participants with PCOS and 240 without PCOS were included based on the Rotterdam criteria. Baseline demographic, anthropometric, laboratory, and body composition parameters were compared between the two groups.

Results

The mean age was 33.7 ± 7.45 years in the PCOS group and 35.49 ± 7.05 years in the control group. The mean BMI was 27.0 ± 4.0 kg/m2 in the PCOS group and 27.1 ± 4.4 kg/m2 in the control group. No significant differences were found in body composition parameters between the two groups as assessed by BIA. Additionally, there were no correlations between body composition and hormone parameters in PCOS patients.

Conclusion

In this sample of non-referral patients with PCOS, the use of BIA did not provide added value beyond conventional anthropometric measures for assessing body composition. Further longitudinal research is needed to determine whether body composition analysis can enhance PCOS evaluation.
Literature
1.
Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod (Oxford England). 2018;33(9):1602–18.CrossRef
2.
3.
Hoeger KM, Dokras A, Piltonen T. Update on PCOS: consequences, challenges, and Guiding Treatment. J Clin Endocrinol Metab. 2021;106(3):e1071–83.CrossRefPubMed
4.
Diamanti-Kandarakis E. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev Mol Med. 2008;10:e3.CrossRefPubMed
5.
Lord J, Wilkin T. Polycystic ovary syndrome and fat distribution: the central issue? Human fertility (Cambridge. England). 2002;5(2):67–71.
6.
7.
Teede HJ, Joham AE, Paul E, Moran LJ, Loxton D, Jolley D, et al. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obes (Silver Spring Md). 2013;21(8):1526–32.CrossRef
8.
Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618–37.CrossRefPubMed
9.
Durmus U, Duran C, Ecirli S. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters. J Endocrinol Investig. 2017;40(5):487–97.CrossRef
10.
Sharma AM, Chetty VT. Obesity, hypertension and insulin resistance. Acta Diabetol. 2005;42(Suppl 1):S3–8.CrossRefPubMed
11.
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (London England). 2004;364(9438):937–52.CrossRefPubMed
12.
Wang J, Thornton JC, Kolesnik S, Pierson RN. Jr. Anthropometry in body composition. An overview. Ann N Y Acad Sci. 2000;904:317–26.CrossRefPubMed
13.
Dagenais GR, Yi Q, Mann JF, Bosch J, Pogue J, Yusuf S. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J. 2005;149(1):54–60.CrossRefPubMed
14.
15.
Diaz EO, Villar J, Immink M, Gonzales T. Bioimpedance or anthropometry? Eur J Clin Nutr. 1989;43(2):129–37.PubMed
16.
Bizoń A, Płaczkowska S, Niepsuj J, Czwojdzińska M, Leśniewski M, Nowak A et al. Body composition and its impact on the hormonal disturbances in women with polycystic ovary syndrome. Nutrients. 2021;13(12).
17.
Geronikolou SA, Bacopoulou F, Cokkinos D. Bioimpedance measurements in adolescents with polycystic ovary syndrome: a pilot study. Adv Exp Med Biol. 2017;987:291–9.CrossRefPubMed
18.
Churchill SJ, Wang ET, Bhasin G, Alexander C, Bresee C, Pall M, et al. Basal metabolic rate in women with PCOS compared to eumenorrheic controls. Clin Endocrinol. 2015;83(3):384–8.CrossRef
19.
Cosar E, Uçok K, Akgün L, Köken G, Sahin FK, Arioz DT, et al. Body fat composition and distribution in women with polycystic ovary syndrome. Gynecol Endocrinology: Official J Int Soc Gynecol Endocrinol. 2008;24(8):428–32.CrossRef
20.
AltuntaŞ M, Aksoy H. Sabuncu T. Comparison of body compositions evaluated with Bioelectrical Impedance Analysis (BIA) with metabolic, hormonal and anthropometric measurements in PCOS patients. J Contemp Med.11(1):29–33.
21.
Attlee A, Nusralla A, Eqbal R, Said H, Hashim M, Obaid RS. Polycystic ovary syndrome in university students: occurrence and associated factors. Int J Fertility Steril. 2014;8(3):261.
22.
Ezeh U, Pall M, Mathur R, Azziz R. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome. Hum Reprod (Oxford England). 2014;29(7):1508–17.CrossRef
23.
Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials. 2009;10:5.CrossRefPubMedPubMedCentral
24.
Ramezani Tehrani F, Behboudi-Gandevani S, Rostami Dovom M, Farahmand M, Minooee S, Noroozzadeh M, et al. Reproductive Assessment: findings from 20 years of the Tehran lipid and glucose study. Int J Endocrinol Metab. 2018;16(4 Suppl):e84786.PubMedPubMedCentral
25.
de Onis M, Habicht JP. Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee. Am J Clin Nutr. 1996;64(4):650–8.CrossRefPubMed
26.
Koo TK, Li MY. A Guideline of selecting and reporting Intraclass correlation coefficients for Reliability Research. J Chiropr Med. 2016;15(2):155–63.CrossRefPubMedPubMedCentral
27.
Momenan AA, Delshad M, Sarbazi N, Rezaei Ghaleh N, Ghanbarian A, Azizi F. Reliability and validity of the modifiable activity questionnaire (MAQ) in an Iranian urban adult population. Arch Iran Med. 2012;15(5):279–82.PubMed
28.
Revised. 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human reproduction (Oxford, England). 2004;19(1):41 – 7.
29.
Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: implications, etiology, and management. Am J Obstet Gynecol. 1981;140(7):815–30.CrossRefPubMed
30.
Pourshahidi LK, Wallace JM, Mulhern MS, Horigan G, Strain JJ, McSorley EM, et al. Indices of adiposity as predictors of cardiometabolic risk and inflammation in young adults. J Hum Nutr Dietetics: Official J Br Diet Association. 2016;29(1):26–37.CrossRef
31.
Kazemi M, Pierson RA, Parry SA, Kaviani M, Chilibeck PD. Obesity, but not hyperandrogenism or insulin resistance, predicts skeletal muscle mass in reproductive-aged women with polycystic ovary syndrome: a systematic review and meta-analysis of 45 observational studies. Obes Reviews: Official J Int Association Study Obes. 2021;22(8):e13255.CrossRef
32.
Lazzer S, Bedogni G, Lafortuna CL, Marazzi N, Busti C, Galli R, et al. Relationship between basal metabolic rate, gender, age, and body composition in 8,780 white obese subjects. Obes (Silver Spring Md). 2010;18(1):71–8.CrossRef
33.
Kim C, Dabelea D, Kalyani RR, Christophi CA, Bray GA, Pi-Sunyer X, et al. Changes in visceral adiposity, Subcutaneous Adiposity, and sex hormones in the diabetes Prevention Program. J Clin Endocrinol Metab. 2017;102(9):3381–9.CrossRefPubMedPubMedCentral
34.
Aubuchon M, Liu Y, Petroski GF, Thomas TR, Polotsky AJ. The impact of supervised weight loss and intentional weight regain on sex hormone binding globulin and testosterone in premenopausal women. Syst Biology Reproductive Med. 2016;62(4):283–9.CrossRef
35.
Akin F, Bastemir M, Alkiş E, Kaptanoglu B. SHBG levels correlate with insulin resistance in postmenopausal women. Eur J Intern Med. 2009;20(2):162–7.CrossRefPubMed
36.
Biernacka-Bartnik A, Kocełak P, Owczarek AJ, Choręza P, Puzianowska-Kuźnicka M, Markuszewski L, et al. Prediction of insulin resistance and impaired fasting glucose based on sex hormone-binding globulin (SHBG) levels in polycystic ovary syndrome. Int J Endocrinol. 2022;2022:6498768.CrossRefPubMedPubMedCentral
37.
Azizi F, Hadaegh F, Hosseinpanah F, Mirmiran P, Amouzegar A, Abdi H, et al. Metabolic health in the Middle East and North Africa. Lancet Diabetes Endocrinol. 2019;7(11):866–79.CrossRefPubMed
38.
Cowan S, Lim S, Alycia C, Pirotta S, Thomson R, Gibson-Helm M, et al. Lifestyle management in polycystic ovary syndrome - beyond diet and physical activity. BMC Endocr Disorders. 2023;23(1):14.CrossRef
39.
Achamrah N, Colange G, Delay J, Rimbert A, Folope V, Petit A, et al. Comparison of body composition assessment by DXA and BIA according to the body mass index: a retrospective study on 3655 measures. PLoS ONE. 2018;13(7):e0200465.CrossRefPubMedPubMedCentral
40.
Sam S. Obesity and polycystic ovary syndrome. Obes Manage. 2007;3(2):69–73.CrossRef
41.
Wild RA, Carmina E, Diamanti-Kandarakis E, Dokras A, Escobar-Morreale HF, Futterweit W, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) society. J Clin Endocrinol Metab. 2010;95(5):2038–49.CrossRefPubMed
Metadata
Title
Body composition analysis in women with polycystic ovary syndrome: a cross-sectional study from the Tehran Lipid and Glucose Study (TLGS)
Authors
Anahita Zakeri
Amir Ebadinejad
Maryam Rahmati
Amir Abbas Momenan
Mahtab Niroomand
Majid Valizadeh
Fereidoun Azizi
Fahimeh Ramezani Tehrani
Farhad Hosseinpanah
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2024
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-024-01783-2

Other articles of this Issue 1/2024

Association between Helicobacter pylori infection and type 2 diabetes mellitus: a retrospective cohort study and bioinformatics analysis

HbA1c changes in a deprived population who followed or not a diabetes self-management programme, organised in a multi-professional primary care practice: a historical cohort study on 207 patients between 2017 and 2019

The mediating effect of sleep duration on metabolic syndrome severity in adults: a structural equation modeling approach

  • Open Access
  • Obesity
  • Original Research

Stevens-Johnson syndrome/toxic epidermal necrolysis complicated with fulminant type 1 diabetes

Combined glucocorticoids and cyclophosphamide in the treatment of Graves’ ophthalmopathy: a systematic review and meta-analysis

Recurrent acromegaly: a systematic review on therapeutic approaches

Keynote webinar | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more
Image Credits